The document discusses the innate immune system. It provides an overview of innate immunity and its major components. Pattern recognition receptors (PRRs) play an important role in innate immunity by recognizing pathogens and damaged cells. The major PRRs discussed are Toll-like receptors (TLRs), NOD-like receptors (NLRs), and RIG-like receptors (RLRs). TLRs recognize pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs). NLRs and RLRs are cytosolic receptors that also recognize PAMPs and DAMPs. Together, these PRRs initiate innate immune responses to infection and damage.
introduction of adaptive immunity. classification of adaptive immunity, factor affecting it and mechanism of adaptive immunity comparison between adaptive immunity and innate immunity. characteristic of adaptive immunity . cell mediated immune responses immunoglobulins
types of immunoglobulins. functions of immunoglobulins, hypersensitivity reactions
A presentation descripes tumors,pathogensis,devlopment,antigenes and genes.
how host responds to them and how tumors evade immunity with latest lines of therapy and prevention.
facaulity of pharmacy.Damascus university.master of libaratory diagnossis. immunology.
Baraa ALomar and feras deban
dendritic cells are part of innate immune system, antigen presenting cells in skin, activation of t cells and inducing and maintaining immune tolerance, 4 types- langerhans cells, dermal dendritic cells, merkel cells, melanocytes
IMMUNE RESPONSE TO TUMORS-Humoral immunity
-Cellular Immunity- Failure of Host Defenses
- Evasion of Immune Responses by Tumors
- Cancer Immunosurveillance vs Immunoediting- Immunotherapy
Adaptive immunity is an immunity that occurs after exposure to an antigen either from a pathogen or a vaccination. This part of the immune system is activated when the innate immune response is insufficient to control an infection. In fact, without information from the innate immune system, the adaptive response could not be mobilized. There are two types of adaptive responses: the cell-mediated immune response, which is carried out by T cells, and the humoral immune response, which is controlled by activated B cells and antibodies.
introduction of adaptive immunity. classification of adaptive immunity, factor affecting it and mechanism of adaptive immunity comparison between adaptive immunity and innate immunity. characteristic of adaptive immunity . cell mediated immune responses immunoglobulins
types of immunoglobulins. functions of immunoglobulins, hypersensitivity reactions
A presentation descripes tumors,pathogensis,devlopment,antigenes and genes.
how host responds to them and how tumors evade immunity with latest lines of therapy and prevention.
facaulity of pharmacy.Damascus university.master of libaratory diagnossis. immunology.
Baraa ALomar and feras deban
dendritic cells are part of innate immune system, antigen presenting cells in skin, activation of t cells and inducing and maintaining immune tolerance, 4 types- langerhans cells, dermal dendritic cells, merkel cells, melanocytes
IMMUNE RESPONSE TO TUMORS-Humoral immunity
-Cellular Immunity- Failure of Host Defenses
- Evasion of Immune Responses by Tumors
- Cancer Immunosurveillance vs Immunoediting- Immunotherapy
Adaptive immunity is an immunity that occurs after exposure to an antigen either from a pathogen or a vaccination. This part of the immune system is activated when the innate immune response is insufficient to control an infection. In fact, without information from the innate immune system, the adaptive response could not be mobilized. There are two types of adaptive responses: the cell-mediated immune response, which is carried out by T cells, and the humoral immune response, which is controlled by activated B cells and antibodies.
Immunity is the ability of the body to defend itself against disease-causing organisms.
The immune system refers to a collection of cells, chemicals and processes that function to protect the body from foreign antigens, such as microbes (organisms, such as bacteria, fungi, and parasites), viruses, cancer cells, and toxins.
The structural and chemical barriers which protect us from infection, the immune system can be classified into two “lines of defense”: innate immunity and adaptive immunity
Exploring the First Line of Defense - Research Tools for Innate Immnity: Host...QIAGEN
The innate immune system executes crucial and unique functions for host defense against infection. This slidedeck provides an overview of the most important cellular and molecular components of innate immunity and discusses their functions in a variety of disease states. Research technologies are also introduced for exploring innate immune activity in your system through profiling of gene expression, cytokine production and signal transduction pathway analysis, all in the context of current literature.
Pattern recognition receptors are type of receptors that plays a major role in innate immunity by recognizing conserved molecular components of the pathogen called pathogens- associated molecular patterns (PAMPs).There are different kinds of PRRS such as soluble pattern recognition receptors and membrane associated PRRs that recognises different kinds of PAMPs such as Carbohydrates,Proteins, lipids and nucleic acids and thereby eliminating the pathogen through different mechanisms.
This presentation answers the following questions!!
How Immune Cells communicate with each other?
Receptors of Immune System?
Receptors of Innate Immune System?
What are PRRS?
What are PAMPS?
What are DAMPS?
What is the structure of PRRS?
What is the mechanism of PRRS?
What are the types of PRRS?
What is the role of PRRS in Immunology?
Learn about novel cell-based assays that enable improved immunotherapy drug development. See case studies utilizing checkpoint receptors such as PD-1, VISTA, and NIK.
these slides includes all basic knowledge about terms, role of immunity, constitution of immune system, cells, molecules, organs, immune system, adaptive and non adaptive immunity, and their mechanisms, Active and Passive immunity, Natural and Artificial immunity also their mechanism, T-Cells and their types, CELL-MEDIATED IMMUNE RESPONSE, HUMORAL IMMUNE RESPONSE, ANTIBODIES (IMMUNOGLOBULINS)
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondHealth Catalyst
Join us as we delve into the crucial realm of quality reporting for MSSP (Medicare Shared Savings Program) Accountable Care Organizations (ACOs).
In this session, we will explore how a robust quality management solution can empower your organization to meet regulatory requirements and improve processes for MIPS reporting and internal quality programs. Learn how our MeasureAble application enables compliance and fosters continuous improvement.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
The Importance of Community Nursing Care.pdfAD Healthcare
NDIS and Community 24/7 Nursing Care is a specific type of support that may be provided under the NDIS for individuals with complex medical needs who require ongoing nursing care in a community setting, such as their home or a supported accommodation facility.
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfSachin Sharma
This content provides an overview of preventive pediatrics. It defines preventive pediatrics as preventing disease and promoting children's physical, mental, and social well-being to achieve positive health. It discusses antenatal, postnatal, and social preventive pediatrics. It also covers various child health programs like immunization, breastfeeding, ICDS, and the roles of organizations like WHO, UNICEF, and nurses in preventive pediatrics.
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
2. OUTLINE
• Overview of the Innate Immunity
• Recognition of Microbes and Damaged Self by Innate Immune System
• Cell-Associated Pattern Recognition Receptors and Sensors of Innate
Immunity
• Cellular Components of the Innate Immune System
• Soluble effector molecules of the Innate Immunity
• Inflammatory Response
• Antiviral response
• Stimulation of Adaptive Immunity
• Mechanism that limit Innate Immune responses
3. Overview of the Innate Immunity
Innate Immunity
• Always present, ready to combat
• Provide early defense
Major Components
• Surface epithelia
• Tissue sentinel cells
• White blood cells
• Plasma proteins
• Overview
• PAMPS & DAMPs
• PRR
• Cellular Components
• Soluble effector
• Inflammatory Response
• Antiviral response
• Stimulation of Adaptive
Immunity
• Mechanism that limit
Innate Immune responses
5. Evolution of Innate Immunity
• The oldest part of the immune system
• Appeared very early in evolution
• When first multicellular organism evolved (~750 million years ago)
• Toll like receptors
• Found in every life form in the evolutionary tree
• Overview
• PAMPS & DAMPs
• PRR
• Cellular Components
• Soluble effector
• Inflammatory Response
• Antiviral response
• Stimulation of Adaptive
Immunity
• Mechanism that limit
Innate Immune responses
8. Recognition of Microbes and Damaged Self by
Innate Immune System
• PAMPS (Pathogen –Associated Molecule pattern)
• DAMPS (Damage-associated molecular patterns)
• Overview
• PAMPS & DAMPs
• PRR
• Cellular Components
• Soluble effector
• Inflammatory Response
• Antiviral response
• Stimulation of Adaptive
Immunity
• Mechanism that limit Innate
Immune responses
9. 9
Innate immunity
The innate immunity is our first line of defense, and relies on cellular and humoral mechanisms
to actively match the invading pathogens as fast as possible. Its main targets are microbes and
cells infected by microbes. The outcome of innate immunity is INFLAMMATION and
activation of the ANTIVIRAL STATE.
Recognition of microbes and infected cells occurs via:
SIGNALS
Damage-Associated
Molecular Patterns
(DAMP)
Damaged/
Infected
cells
RECEPTORS
Pathogen-Associated
Molecular Patterns
(PAMP)
Microbes
TLRs, RIGs, NOD,
Mannose receptor,
Dectins, Scavenger
receptors
Phagocytes
Antibodies,
complement system,
antimicrobial
peptides
Mucosae and
circulating
• Overview
• PAMPS & DAMPs
• PRR
• Cellular Components
• Soluble effector
• Inflammatory Response
• Antiviral response
• Stimulation of Adaptive
Immunity
• Mechanism that limit Innate
Immune responses
10. Recognition of Microbes and Damaged Self by
Innate Immune System
PAMPS (Pathogen –Associated Molecule pattern)
• Structures produced by microorganisms which are
recognized by and stimulate the innate immune system
DAMPS (Damage-associated molecular patterns)
• Endogenous molecules that are produced or released
from damaged and dying cells that bind to Pattern
recognition receptor stimulation of innate immune
response
• Overview
• PAMPS & DAMPs
• PRR
• Cellular Components
• Soluble effector
• Inflammatory Response
• Antiviral response
• Stimulation of Adaptive
Immunity
• Mechanism that limit Innate
Immune responses
16. Pattern recognition receptors
• Structure: several families of
protein
• Location: expressed on many
effector cells
• 2 locations:
1. Transmembrane
2. Cystosolic
17. Pattern recognition receptors
• Signaling receptors of the innate immunity that
recognize PAMPs and DAMPS activation of the
innate immune system
• Binding to PAMPs and DAMPs activation of
signal transduction promotion of antimicrobial
and pro-inflammatory functions of the cells
• Responsible for facilitating clearance of microbes
from blood and ECF by enhancing uptake into
phagocytes or activating extracellular killing
mechanism
• Overview
• PAMPS & DAMPs
• PRR
• Cellular Components
• Soluble effector
• Inflammatory Response
• Antiviral response
• Stimulation of Adaptive
Immunity
• Mechanism that limit Innate
Immune responses
21. Toll like receptors
• 9 different functional TLRs in
humans (TLR 1-9)
• Mammalian TLR are involved in
responses to a wide variety of
molecules that are expressed by
microbes (but not by healthy
mammalian cells)
• Found in the cell surface and
intracellular membranes
• Thus are able to recognize microbes in
different locations
22. Toll like receptors
• Type 1 integral membrane
glycoproteins
• Contain leucine-rich repeats flanked
by characteristic cysteine-rich motif in
their extracellular region (involved in
ligand binding)
• Toll /Il-1 receptor (TIR) domain in
cytoplasmic tails (essential for
signaling)
• Also found in the cytoplasmic tails
of the receptor for cytokines IL-1
and IL-
23. Toll-like receptors (TLRs)
• They exist as membrane-bound and cytosolic
form
• Show the widest ability to recognize PAMPs.
They also recognize DAMPs
• In humans 9 TLRs are known (TLR 1-9).
Abbas et al.
• TLR 1,2,4,5,6
• Plasma membrane
• TLR 3,7,8,9
• Inside the cell (endoplasmic
reticulum and endosomal
membrane)
Bacterial
products
that bind
to TLR
24. Toll like receptors
• Involved in responses to endogenous molecules whose expression or
location indicates cell damage
• Heat shock protein (HSP) and high-mobility group box 1 (HMGB1) are
intracellular becomes extracellular when released from injured or dying
cell
• From extracellular region activate via TLR2 & TLR4 signaling in Dendritic
ells, macrophage and other cell types
• Structural basis
• Resides on the multiple extracellular leucine rich modules of these receptors
(that bind directly to PAMPs or adaptor molecules that bind to PAMPs)
25. Signaling
Pathways
of TLRs
Products of the pathway are
important for:
• Inflammation
• Anti-viral response
• Overview
• PAMPS & DAMPs
• PRR
• Cellular Components
• Soluble effector
• Inflammatory Response
• Antiviral response
• Stimulation of Adaptive
Immunity
• Mechanism that limit Innate
Immune responses
26. Pattern recognition receptors
• Structure: several families of
protein
• Location: expressed on many
effector cells
• 2 locations:
1. Transmembrane
2. Cystosolic
28. Cystosolic Receptors
NOD-like receptors (NLRs)
• cytosolic receptors for PAMPs and DAMPs
• More than 20 NLRs are known, but the best characterized
are NOD1 and NOD2
• NOD1 and NOD2 are especially important against Helicobacter
pylori
• NOD1
• recognizes preferentially bacterial peptidoglycans
• NOD2
• recognizes muramyl dipeptide from Gram+ and Gram- bacteria.
• defects in NOD2 might be involved in Chron’s disease.
• NLRs activation leads to gene activation in a similar way to
TLRs. and
• Overview
• PAMPS & DAMPs
• PRR
• Cellular Components
• Soluble effector
• Inflammatory Response
• Antiviral response
• Stimulation of Adaptive
Immunity
• Mechanism that limit Innate
Immune responses
29.
30. Cystosolic Receptors
RIG-like receptors (RLRs)
• cytosolic receptors for viral RNA (both ssRNA and
dsRNA).
• Best characterized RLRs are RIG-I and MDA5, which
recognize different viral nucleic acids.
• Once activated, they will lead to transcription of
Type-I interferons and antiviral defenses activation.
• These include suppression of transcription factors needed
for viral genes (like EIF2a), the synthesis of RNAse which
degrade viral RNA and suppression of viral proteins
assembly complexes.
• Overview
• PAMPS & DAMPs
• PRR
• Cellular Components
• Soluble effector
• Inflammatory Response
• Antiviral response
• Stimulation of Adaptive
Immunity
• Mechanism that limit Innate
Immune responses
31. Cystosolic Receptors
Cystosolic DNA sensors
• Molecules that detect microbial double-stranded
(ds)DNA in the cytosol activates signaling pathway
initiation of antimicrobial response
STING pathway (stimulator of IFN genes)
• An important mechanismof dsDNA-induced activation
of type-1 interferon responses
• Overview
• PAMPS & DAMPs
• PRR
• Cellular Components
• Soluble effector
• Inflammatory Response
• Antiviral response
• Stimulation of Adaptive
Immunity
• Mechanism that limit Innate
Immune responses
38. C-Type Lectin Receptors
• Microbial carbohydrates are recognized by calcium-dependent Lectins
(C-type Lectins). These include:
• Mannose receptor (CD206), which recognizes D-mannose, L-fucose
and N-acetyl-D-glucosamine.
• Dectins, which recognize fungal b-glucan (dectin-1) and mannose-
rich oligosaccharides (dectin-2).
• Langherin (CD207), DC-SIGN, and others
39.
40.
41. N-FMLP receptors
• N-FMLP receptors (like FPR and FPRL1)
• Those receptors bind to n-formylmethionine leucyl-phenylalanine, a
sequence which characterizes all bacterial proteins but not human
ones (apart from mitochondrial proteins).
43. Abbas et al.
Epithelia:
- Physical barrier
- Defensive molecules
Circulating defenses:
- Natural antibodies
- The Complement system
Cellular defenses:
- Phagocytes
- NK cells
• Overview
• PAMPS & DAMPs
• PRR
• Cellular Components
• Soluble effector
• Inflammatory Response
• Antiviral response
• Stimulation of Adaptive
Immunity
• Mechanism that limit Innate
Immune responses
44. Epithelia play a big role in the very first match with invading
pathogens. As most of the microbes enter the body via the
skin, the respiratory and the gastrointestinal tract, these
epithelia evolved specific strategies to counteract
pathogens, like:
• Expression of sialomucins on the external side of the
plasma membrane, which electrostatically repel
bacterial walls
• Production of antimicrobial peptides (like defensins and
cathelicidins), which both directly attack the microbes
and help their recognition by innate immunity cells
• Hosting of intraepithelial lymphocytes. While some of
them are “classical” ab T-cells, many are gd T-cells,
which are particularly good at recognizing bacterial
phospholipids. They can directly attack microbes and
stimulate phagocyte responses.
45. Abbas et al.
Epithelia:
- Physical barrier
- Defensive molecules
Circulating defenses:
- Natural antibodies
- The Complement system
Cellular defenses:
- Phagocytes
- NK cells
• Overview
• PAMPS & DAMPs
• PRR
• Cellular Components
• Soluble effector
• Inflammatory Response
• Antiviral response
• Stimulation of Adaptive
Immunity
• Mechanism that limit Innate
Immune responses
46. Phagocytes
• Cells that have specialized phagocytic function, primarily
macrophages and neutrophils are the first line of defense against
microbes that breach the epithelial barrier
47.
48. Dendritic Cells
• Rapidly and efficiently detect invading microbes because of:
• their location in the tissue
• Expression of numerous PRR fro PAMPs and DAMPs
49. Cytokine-Producing Innate Lymphoid Cells
• 3 subsets of innate lymphoid
cells called:
• ILC1,ILC2 and ILC3
• Produce different cytokines
• Express different transcription
factors, analogous to Th1, Th2
and Th17 of CD4 T
lymphocytes subset
50. Natural Killer Cells
Effector function of NK cells are to :
• Kill infected cells
• Produce IFN-γ, which activates
macrophages to destroy
phagocytosed microbes
• First known ILC
• Cytotoxic cells that play important
roles in innate immune response
• Overview
• PAMPS & DAMPs
• PRR
• Cellular Components
• Soluble effector
• Inflammatory Response
• Antiviral response
• Stimulation of Adaptive
Immunity
• Mechanism that limit Innate
Immune responses
52. Structure and ligands of activating and inhibitory receptors of NK Cells
• Overview
• PAMPS & DAMPs
• PRR
• Cellular Components
• Soluble effector
• Inflammatory Response
• Antiviral response
• Stimulation of Adaptive
Immunity
• Mechanism that limit Innate
Immune responses
53. Soluble Effector Molecules of Innate
Immunity
• The Complement System
• Pentraxims
• Collectins and Ficolins
• Overview
• PAMPS & DAMPs
• PRR
• Cellular Components
• Soluble effector
• Inflammatory Response
• Antiviral response
• Stimulation of Adaptive
Immunity
• Mechanism that limit Innate
Immune responses
54. Abbas et al.
Epithelia:
- Physical barrier
- Defensive molecules
Circulating defenses:
- Natural antibodies
- The Complement system
Cellular defenses:
- Phagocytes
- NK cells
• Overview
• PAMPS & DAMPs
• PRR
• Cellular Components
• Soluble effector
• Inflammatory Response
• Antiviral response
• Stimulation of Adaptive
Immunity
• Mechanism that limit Innate
Immune responses
55. The complement system is a network of many (> 20) soluble and membrane-
bound proteins which are normally present in the blood flow in the form of
inactive precursors (pro-enzymes).
The term complement (C) was used to refer to a heat-instable serum
component which was able to lyse bacteria when incubated at 37oC, but lost
when incubated at 56oC for 30 minutes (antibodies are thermo stable!).
• The complement system is activated by microbial macromolecules or by
antibodies bound to them. There are 3 complement activation pathways.
• Complement activation proceeds through sequential cleavage and
activation of circulating inactive forms of C proteins. Once cleaved, those
precursors become active and acquire proteolytic activity.
Jules Bordet
56. The Complement System
• The final stages of complement activation lead to formation of MAC (Membrane
Attack Complex), which is a canal (similar to acquaporins) structure allowing
water to enter into the microbes and kill them by osmotic lysis.
• Microbes bound to complement fragments can be more-easily recognized and
killed by phagocytes
• Self cells, but not microbes, express proteins which inhibit complement
activation.
Jules Bordet
58. C3 has a spontaneous
cleavage turnover in
body fluids, so it can
directly recognize
microbes.
The classical and
lectins pathway
provide specificity to
complement activation
Abbas et al.
59. Pentraxins
• Pentraxins
• A family of plasma proteins that contain 5 identical
globular subuntis
• Includes acute phase reactant, CRP
• ↑ CRP is a result of increased synthesis by the liver
induced by IL-6 and IL-1
• Overview
• PAMPS & DAMPs
• PRR
• Cellular Components
• Soluble effector
• Inflammatory Response
• Antiviral response
• Stimulation of Adaptive
Immunity
• Mechanism that limit Innate
Immune responses
60. Collectin and Ficolin
• Collectin
• Family of trimeric or hexameric proteins
• Contains a collagen-like tail connected by a neck region to a
calcium-dependent (C-type) lectin head
• 3 members that are soluble effectors of the innate
immunity
1. MBL (Mannose binding protein)
2. Surfactant Protein A (SP-A)
3. Surfactant Protein D(SP-D)
• Overview
• PAMPS & DAMPs
• PRR
• Cellular Components
• Soluble effector
• Inflammatory Response
• Antiviral response
• Stimulation of Adaptive
Immunity
• Mechanism that limit Innate
Immune responses
61. Collectin and Ficolin
• Ficolins
• Plasma proteins that are structurally similar to
collectins
• Possess a collagen-like domain that have a
fibrinogen-type carbohydrate recognition domain
(instead of a C-type lectin)
• Bind to several species of bacteria, opsonizing
them and activating complement in a manner
similar to MBL
• Overview
• PAMPS & DAMPs
• PRR
• Cellular Components
• Soluble effector
• Inflammatory Response
• Antiviral response
• Stimulation of Adaptive
Immunity
• Mechanism that limit Innate
Immune responses
63. Inflammatory Response
• The Major Proinflammatory Cytokines of Innate Immunity
• Tumor Necrosis Factor
• Interleukin -1
• Interleukin 6
• Other Cytokines
• Recruitment of Leukocytes to the Sites of Infection
• Ingestion and Killing of Microbes by Activated Phagocytes
• Systemic and Pathologic Consequences of Inflammation
64. Acute inflammation
• Principal way by which innate immune system
deals with infection and tissue injury
• There is an accumulation of leukocytes, plasma
proteins and fluid derived from blood at an
extravascular tissue site of infection or injury
• Overview
• PAMPS & DAMPs
• PRR
• Cellular Components
• Soluble effector
• Inflammatory
Response
• Antiviral response
• Stimulation of Adaptive
Immunity
• Mechanism that limit
Innate Immune responses
65. General properties
• Produced mainly by tissue macrophage and dendritic
cells
• Most cytokines act on cells close to their cell of origin
(paracrine action)
• Cytokines produced: TNF, IL-17, IL-5, IFN-γ
• Role of cytokines of innate immunity
• Induces inflammation
• Inhibits viral replication
• Promotes T cell response
• Overview
• PAMPS & DAMPs
• PRR
• Cellular Components
• Soluble effector
• Inflammatory
Response
• Antiviral response
• Stimulation of Adaptive
Immunity
• Mechanism that limit
Innate Immune responses
66.
67. General properties
THREE MOST IMPORTANT PRO-INFLAMMATORY
CYTOKINES OF THE INNATE IMMUNITY
1. Tumor Necrosis Factor
2. IL-1
3. IL-6
• Overview
• PAMPS & DAMPs
• PRR
• Cellular Components
• Soluble effector
• Inflammatory
Response
• Antiviral response
• Stimulation of Adaptive
Immunity
• Mechanism that limit
Innate Immune responses
75. Systemic and Pathologic consequence of
inflammation
• TNF, IL-1 and IL-6
• Are produced during the innate immune response to
infection or tissue damage
• TNF and IL-1
• Act on hypothalamus to induce an increase in temperature
• IL-1 and IL-6
• Induce hepatocytes to produce acute phase reactant
• Overview
• PAMPS & DAMPs
• PRR
• Cellular Components
• Soluble effector
• Inflammatory
Response
• Antiviral response
• Stimulation of Adaptive
Immunity
• Mechanism that limit
Innate Immune responses
77. The Anti-Viral Response
• The major way by which the innate immune system
blocks viral infection is to induce the expression of Type
1 interferon
• Type 1 interferon
• Large family of structurally related cytokines that mediate the
early innate immune response to viral infections
• Most important action is to inhibit viral replication
• Overview
• PAMPS & DAMPs
• PRR
• Cellular Components
• Soluble effector
• Inflammatory Response
• Antiviral response
• Stimulation of Adaptive
Immunity
• Mechanism that limit Innate
Immune responses
79. Stimulation of Adaptive Immunity
Innate immunity
• Provides signals that function in concert with antigen
to stimulate the proliferation and differentiation of
antigen-specific T and B lymphocytes
• Two signal hypothesis
• Overview
• PAMPS & DAMPs
• PRR
• Cellular Components
• Soluble effector
• Inflammatory Response
• Antiviral response
• Stimulation of Adaptive
Immunity
• Mechanism that limit Innate
Immune responses
80. Two signal hypothesis
• Overview
• PAMPS & DAMPs
• PRR
• Cellular Components
• Soluble effector
• Inflammatory Response
• Antiviral response
• Stimulation of Adaptive
Immunity
• Mechanism that limit Innate
Immune responses
81. Mechanisms that limit Innate Immunity
• Regulated by a variety of inhibitory mechanisms
that limit potential damage to tissues
• IL-10
• Cytokine that is produced by and inhibits the activation
of macrophages and dendritic cells
• Excellent example of a negative feedback regulator
• Produced by nonlymphoid cell types and regulatory T
cells
• Overview
• PAMPS & DAMPs
• PRR
• Cellular Components
• Soluble effector
• Inflammatory Response
• Antiviral response
• Stimulation of Adaptive Immunity
• Mechanism that
limit Innate
Immune responses
82. Mechanisms that limit Innate Immunity
IL-1 receptor antagonist (IL-IRA)
• Natural antagonist of IL-1 that is structurally
homologous to the cytokine
• Competitive inhibitor of IL-1
Autophagy genes
• Products regulate the secretion of inflammatory
cytokines
• Overview
• PAMPS & DAMPs
• PRR
• Cellular Components
• Soluble effector
• Inflammatory Response
• Antiviral response
• Stimulation of Adaptive Immunity
• Mechanism that
limit Innate
Immune responses
TLRs are express on the cell surface and others in endosomes (it may form a homodimer or heterodimers
TLR
FIGURE 4-3 Signaling pathways and
functions of TLRs. TLRs 1, 2, 5, and 6 use
the adaptor protein MyD88 and activate the
transcription factors NF-κB and AP-1. TLR3
uses the adaptor protein TRIF and activates the
IRF3 and IRF7 transcription factors. TLR4 can
activate both pathways. TLRs 7 and 9 in the
endosome use MyD88 and activate both NF-
κB and IRF7.
Other microbial PAMPs are recognized by:
Scavenger receptors (like SR-A and CD36). Initially identified as receptors for oxidized LDL (involved in atherosclerosis), they bind to bacterial polyanions (LPS, LTA, nucleic acids etc.).
Nk cells recognize ligands on infected cells or cells undergoing other types of stress and kill cells
Nk cells respond to IL-12 produced by macrophage to kill phagocytosed microbes
Nk cells distinguish infected and stressed cells from healthy cells and NK cell function is regulated by a balance between signals that are generated from activating receptors and inhibitory receptors
Steps: Type 1 interferon, signaling thru the Type 1 interferon receptor activate several genes that confer resistance to viral infection called an ANTIVIRAL STATE
Type 1 interferon are produced by virus-infected cell in response to TLR signaling Type 1 interferon binds to receptor of unifected cells Activate the JAK-STAT signaling pathway induces the expression of genes whose products interfere with viral replication
Type 1 interferon also binds to receptors of infected cells and induce expression of genes whose products enhance the cell’s susceptibility to CTL mediated killing
Antigen recognition by lymphocytes provides signal #1 for activation of lymphocytes
Molecules induced by inate response provides signal #1